Skip to main content
Erschienen in: Calcified Tissue International 5/2010

01.05.2010

Variation in the PTH Gene, Hip Fracture, and Femoral Neck Geometry in Elderly Women

verfasst von: M. Tenne, F. E. McGuigan, H. Ahlborg, P. Gerdhem, K. Åkesson

Erschienen in: Calcified Tissue International | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Parathyroid hormone (PTH) is a principal regulator of calcium homeostasis. Previously, we studied single-nucleotide polymorphisms present in the major genes in the PTH pathway (PTH, PTHrP, PTHR1, PTHR2) in relation to bone mineral density (BMD) and fracture incidence. We found that haplotypes of the PTH gene were associated with fracture risk independent of BMD. In the present study, we evaluated the relationship between PTH haplotypes and femoral neck bone size. Hip structure analysis and BMD of the femoral neck was assessed by DXA in elderly women from the Malmö Osteoporosis Prospective Risk Assessment study. Data on hip fracture, sustained as a result of low trauma, after the age of 45 years were also analyzed. Haplotypes derived from six polymorphisms in the PTH locus were analyzed in 750 women. Carriers of haplotype 9 had lower values for hip geometry parameters cross-sectional moment of inertia (P = 0.029), femoral neck width (P = 0.049), and section modulous (P = 0.06), suggestive of increased fracture risk at the hip. However, this did not translate into an increased incidence of hip fracture in the studied population. Women who suffered a hip fracture compared to those who had not had longer hip axis length (HAL) (P < 0.001). HAL was not significantly different among haplotypes. Polymorphisms in the PTH gene are associated with differences in aspects of femoral neck geometry in elderly women; however, the major predictor of hip fracture in our population was HAL, to which PTH gene variation does not contribute significantly.
Literatur
1.
Zurück zum Zitat Melton LJ 3rd (1993) Hip fractures: a worldwide problem today and tomorrow. Bone 14(Suppl 1):S1–S8CrossRefPubMed Melton LJ 3rd (1993) Hip fractures: a worldwide problem today and tomorrow. Bone 14(Suppl 1):S1–S8CrossRefPubMed
2.
Zurück zum Zitat Cooper C, Campion G, Melton LJ 3rd (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289CrossRefPubMed Cooper C, Campion G, Melton LJ 3rd (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289CrossRefPubMed
3.
Zurück zum Zitat Arden NK et al (1996) The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins. J Bone Miner Res 11:530–534CrossRefPubMed Arden NK et al (1996) The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins. J Bone Miner Res 11:530–534CrossRefPubMed
4.
Zurück zum Zitat Koller DL et al (2001) Genome screen for quantitative trait loci underlying normal variation in femoral structure. J Bone Miner Res 16:985–991CrossRefPubMed Koller DL et al (2001) Genome screen for quantitative trait loci underlying normal variation in femoral structure. J Bone Miner Res 16:985–991CrossRefPubMed
5.
Zurück zum Zitat Flicker L et al (1996) Determinants of hip axis length in women aged 10–89 years: a twin study. Bone 18:41–45CrossRefPubMed Flicker L et al (1996) Determinants of hip axis length in women aged 10–89 years: a twin study. Bone 18:41–45CrossRefPubMed
6.
Zurück zum Zitat Slemenda CW et al (1996) The genetics of proximal femur geometry, distribution of bone mass and bone mineral density. Osteoporos Int 6:178–182CrossRefPubMed Slemenda CW et al (1996) The genetics of proximal femur geometry, distribution of bone mass and bone mineral density. Osteoporos Int 6:178–182CrossRefPubMed
7.
Zurück zum Zitat Deng FY, Zhao LJ, Pei YF et al (2010) Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in Caucasians. Osteoporos Int 21:579–587CrossRefPubMed Deng FY, Zhao LJ, Pei YF et al (2010) Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in Caucasians. Osteoporos Int 21:579–587CrossRefPubMed
8.
Zurück zum Zitat Howard GM et al (1998) Genetic and environmental contributions to the association between quantitative ultrasound and bone mineral density measurements: a twin study. J Bone Miner Res 13:1318–1327CrossRefPubMed Howard GM et al (1998) Genetic and environmental contributions to the association between quantitative ultrasound and bone mineral density measurements: a twin study. J Bone Miner Res 13:1318–1327CrossRefPubMed
9.
Zurück zum Zitat Beamer WG et al (1996) Genetic variability in adult bone density among inbred strains of mice. Bone 18:397–403CrossRefPubMed Beamer WG et al (1996) Genetic variability in adult bone density among inbred strains of mice. Bone 18:397–403CrossRefPubMed
10.
Zurück zum Zitat Nordstrom A et al (2004) Interleukin-6 promoter polymorphism is associated with bone quality assessed by calcaneus ultrasound and previous fractures in a cohort of 75-year-old women. Osteoporos Int 15:820–826CrossRefPubMed Nordstrom A et al (2004) Interleukin-6 promoter polymorphism is associated with bone quality assessed by calcaneus ultrasound and previous fractures in a cohort of 75-year-old women. Osteoporos Int 15:820–826CrossRefPubMed
11.
Zurück zum Zitat Langdahl BL et al (2003) Polymorphisms in the transforming growth factor beta 1 gene and osteoporosis. Bone 32:297–310CrossRefPubMed Langdahl BL et al (2003) Polymorphisms in the transforming growth factor beta 1 gene and osteoporosis. Bone 32:297–310CrossRefPubMed
12.
Zurück zum Zitat Brommage R et al (1999) Daily treatment with human recombinant parathyroid hormone-(1–34), LY333334, for 1 year increases bone mass in ovariectomized monkeys. J Clin Endocrinol Metab 84:3757–3763CrossRefPubMed Brommage R et al (1999) Daily treatment with human recombinant parathyroid hormone-(1–34), LY333334, for 1 year increases bone mass in ovariectomized monkeys. J Clin Endocrinol Metab 84:3757–3763CrossRefPubMed
13.
Zurück zum Zitat Neer M et al (1993) Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol. Osteoporos Int 3(Suppl 1):204–205CrossRefPubMed Neer M et al (1993) Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol. Osteoporos Int 3(Suppl 1):204–205CrossRefPubMed
14.
Zurück zum Zitat Hodsman AB et al (2003) Efficacy and safety of human parathyroid hormone-(1–84) in increasing bone mineral density in postmenopausal osteoporosis. J Clin Endocrinol Metab 88:5212–5220CrossRefPubMed Hodsman AB et al (2003) Efficacy and safety of human parathyroid hormone-(1–84) in increasing bone mineral density in postmenopausal osteoporosis. J Clin Endocrinol Metab 88:5212–5220CrossRefPubMed
15.
Zurück zum Zitat Chen P et al (2007) Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis. J Bone Miner Res 22:1173–1180CrossRefPubMed Chen P et al (2007) Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis. J Bone Miner Res 22:1173–1180CrossRefPubMed
16.
Zurück zum Zitat Recker RR et al (2009) Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1–84. Bone 44:113–119CrossRefPubMed Recker RR et al (2009) Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1–84. Bone 44:113–119CrossRefPubMed
17.
Zurück zum Zitat Body JJ et al (2002) A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1–34)] with alendronate in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 87:4528–4535CrossRefPubMed Body JJ et al (2002) A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1–34)] with alendronate in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 87:4528–4535CrossRefPubMed
18.
Zurück zum Zitat Stroup JS et al (2007) Two-year changes in bone mineral density and T scores in patients treated at a pharmacist-run teriparatide clinic. Pharmacotherapy 27:779–788CrossRefPubMed Stroup JS et al (2007) Two-year changes in bone mineral density and T scores in patients treated at a pharmacist-run teriparatide clinic. Pharmacotherapy 27:779–788CrossRefPubMed
19.
20.
Zurück zum Zitat Stewart AF et al (1980) Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N Engl J Med 303:1377–1383PubMedCrossRef Stewart AF et al (1980) Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N Engl J Med 303:1377–1383PubMedCrossRef
21.
Zurück zum Zitat Tenne M et al (2008) Genetic variation in the PTH pathway and bone phenotypes in elderly women: evaluation of PTH, PTHLH, PTHR1 and PTHR2 genes. Bone 42:719–727CrossRefPubMed Tenne M et al (2008) Genetic variation in the PTH pathway and bone phenotypes in elderly women: evaluation of PTH, PTHLH, PTHR1 and PTHR2 genes. Bone 42:719–727CrossRefPubMed
22.
Zurück zum Zitat Gerdhem P et al (2004) Association of the collagen type 1 (COL1A 1) Sp1 binding site polymorphism to femoral neck bone mineral density and wrist fracture in 1044 elderly Swedish women. Calcif Tissue Int 74:264–269CrossRefPubMed Gerdhem P et al (2004) Association of the collagen type 1 (COL1A 1) Sp1 binding site polymorphism to femoral neck bone mineral density and wrist fracture in 1044 elderly Swedish women. Calcif Tissue Int 74:264–269CrossRefPubMed
23.
Zurück zum Zitat Gerdhem P et al (2005) Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporos Int 16:1425–1431CrossRefPubMed Gerdhem P et al (2005) Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporos Int 16:1425–1431CrossRefPubMed
24.
Zurück zum Zitat Gerdhem P, Akesson K (2007) Rates of fracture in participants and non-participants in the Osteoporosis Prospective Risk Assessment study. J Bone Joint Surg Br 89:1627–1631CrossRefPubMed Gerdhem P, Akesson K (2007) Rates of fracture in participants and non-participants in the Osteoporosis Prospective Risk Assessment study. J Bone Joint Surg Br 89:1627–1631CrossRefPubMed
25.
Zurück zum Zitat Gerdhem P et al (2007) Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women. J Bone Miner Res 22:127–134CrossRefPubMed Gerdhem P et al (2007) Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women. J Bone Miner Res 22:127–134CrossRefPubMed
26.
Zurück zum Zitat Yoshikawa T et al (1994) Geometric structure of the femoral neck measured using dual-energy X-ray absorptiometry. J Bone Miner Res 9:1053–1064CrossRefPubMed Yoshikawa T et al (1994) Geometric structure of the femoral neck measured using dual-energy X-ray absorptiometry. J Bone Miner Res 9:1053–1064CrossRefPubMed
27.
Zurück zum Zitat Karlsson MK et al (1998) Bone mineral density assessed by quantitative ultrasound and dual energy X-ray absorptiometry. Normative data in Malmo, Sweden. Acta Orthop Scand 69:189–193PubMed Karlsson MK et al (1998) Bone mineral density assessed by quantitative ultrasound and dual energy X-ray absorptiometry. Normative data in Malmo, Sweden. Acta Orthop Scand 69:189–193PubMed
28.
Zurück zum Zitat Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978–989CrossRefPubMed Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978–989CrossRefPubMed
29.
Zurück zum Zitat Dong SS et al (2009) Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians. Calcif Tissue Int 85:104–112CrossRefPubMed Dong SS et al (2009) Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians. Calcif Tissue Int 85:104–112CrossRefPubMed
30.
Zurück zum Zitat Cho K et al (2008) Polymorphisms in the endothelial nitric oxide synthase gene and bone density/ultrasound and geometry in humans. Bone 42:53–60CrossRefPubMed Cho K et al (2008) Polymorphisms in the endothelial nitric oxide synthase gene and bone density/ultrasound and geometry in humans. Bone 42:53–60CrossRefPubMed
31.
Zurück zum Zitat Rivadeneira F et al (2006) Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women. J Bone Miner Res 21:1443–1456CrossRefPubMed Rivadeneira F et al (2006) Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women. J Bone Miner Res 21:1443–1456CrossRefPubMed
32.
Zurück zum Zitat Moffett SP et al (2005) Tumor necrosis factor-alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women. J Clin Endocrinol Metab 90:3491–3497CrossRefPubMed Moffett SP et al (2005) Tumor necrosis factor-alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women. J Clin Endocrinol Metab 90:3491–3497CrossRefPubMed
33.
Zurück zum Zitat Yerges LM et al (2009) Functional characterization of genetic variation in the Frizzled 1 (FZD1) promoter and association with bone phenotypes: more to the LRP5 story? J Bone Miner Res 24:87–96CrossRefPubMed Yerges LM et al (2009) Functional characterization of genetic variation in the Frizzled 1 (FZD1) promoter and association with bone phenotypes: more to the LRP5 story? J Bone Miner Res 24:87–96CrossRefPubMed
34.
Zurück zum Zitat Zmuda JM et al (2009) Association analysis of WNT10B with bone mass and structure among individuals of African ancestry. J Bone Miner Res 24:437–447CrossRefPubMed Zmuda JM et al (2009) Association analysis of WNT10B with bone mass and structure among individuals of African ancestry. J Bone Miner Res 24:437–447CrossRefPubMed
35.
Zurück zum Zitat Rivadeneira F et al (2004) The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: the Rotterdam Study. J Bone Miner Res 19:1280–1290CrossRefPubMed Rivadeneira F et al (2004) The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: the Rotterdam Study. J Bone Miner Res 19:1280–1290CrossRefPubMed
36.
Zurück zum Zitat Gong G et al (1999) Association of bone dimensions with a parathyroid hormone gene polymorphism in women. Osteoporos Int 9:307–311CrossRefPubMed Gong G et al (1999) Association of bone dimensions with a parathyroid hormone gene polymorphism in women. Osteoporos Int 9:307–311CrossRefPubMed
37.
Zurück zum Zitat Ahlborg HG et al (2005) Contribution of hip strength indices to hip fracture risk in elderly men and women. J Bone Miner Res 20:1820–1827CrossRefPubMed Ahlborg HG et al (2005) Contribution of hip strength indices to hip fracture risk in elderly men and women. J Bone Miner Res 20:1820–1827CrossRefPubMed
38.
Zurück zum Zitat Faulkner KG et al (2006) Femur strength index predicts hip fracture independent of bone density and hip axis length. Osteoporos Int 17:593–599CrossRefPubMed Faulkner KG et al (2006) Femur strength index predicts hip fracture independent of bone density and hip axis length. Osteoporos Int 17:593–599CrossRefPubMed
39.
Zurück zum Zitat Beck TJ (2007) Extending DXA beyond bone mineral density: understanding hip structure analysis. Curr Osteoporos Rep 5:49–55CrossRefPubMed Beck TJ (2007) Extending DXA beyond bone mineral density: understanding hip structure analysis. Curr Osteoporos Rep 5:49–55CrossRefPubMed
40.
Zurück zum Zitat Gregory JS, Aspden RM (2008) Femoral geometry as a risk factor for osteoporotic hip fracture in men and women. Med Eng Phys 30:1275–1286CrossRefPubMed Gregory JS, Aspden RM (2008) Femoral geometry as a risk factor for osteoporotic hip fracture in men and women. Med Eng Phys 30:1275–1286CrossRefPubMed
41.
Zurück zum Zitat Gluer CC et al (1994) Prediction of hip fractures from pelvic radiographs: the study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 9:671–677CrossRefPubMed Gluer CC et al (1994) Prediction of hip fractures from pelvic radiographs: the study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 9:671–677CrossRefPubMed
42.
Zurück zum Zitat Duan Y et al (2003) Structural and biomechanical basis of sexual dimorphism in femoral neck fragility has its origins in growth and aging. J Bone Miner Res 18:1766–1774CrossRefPubMed Duan Y et al (2003) Structural and biomechanical basis of sexual dimorphism in femoral neck fragility has its origins in growth and aging. J Bone Miner Res 18:1766–1774CrossRefPubMed
43.
Zurück zum Zitat Lei SF et al (2005) The VDR, COL1A1, PTH, and PTHR1 gene polymorphisms are not associated with bone size and height in Chinese nuclear families. J Bone Miner Metab 23:501–505CrossRefPubMed Lei SF et al (2005) The VDR, COL1A1, PTH, and PTHR1 gene polymorphisms are not associated with bone size and height in Chinese nuclear families. J Bone Miner Metab 23:501–505CrossRefPubMed
44.
Zurück zum Zitat Uusi-Rasi K et al (2005) Effects of teriparatide [rhPTH (1–34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women. Bone 36:948–958CrossRefPubMed Uusi-Rasi K et al (2005) Effects of teriparatide [rhPTH (1–34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women. Bone 36:948–958CrossRefPubMed
45.
Zurück zum Zitat Parkinson DB, Thakker RV (1992) A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism. Nat Genet 1:149–152CrossRefPubMed Parkinson DB, Thakker RV (1992) A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism. Nat Genet 1:149–152CrossRefPubMed
46.
Zurück zum Zitat Kilav R, Silver J, Naveh-Many T (2001) A conserved cis-acting element in the parathyroid hormone 3’-untranslated region is sufficient for regulation of RNA stability by calcium and phosphate. J Biol Chem 276:8727–8733CrossRefPubMed Kilav R, Silver J, Naveh-Many T (2001) A conserved cis-acting element in the parathyroid hormone 3’-untranslated region is sufficient for regulation of RNA stability by calcium and phosphate. J Biol Chem 276:8727–8733CrossRefPubMed
47.
Zurück zum Zitat Kaptoge S et al (2008) Prediction of incident hip fracture risk by femur geometry variables measured by hip structural analysis in the study of osteoporotic fractures. J Bone Miner Res 23:1892–1904CrossRefPubMed Kaptoge S et al (2008) Prediction of incident hip fracture risk by femur geometry variables measured by hip structural analysis in the study of osteoporotic fractures. J Bone Miner Res 23:1892–1904CrossRefPubMed
Metadaten
Titel
Variation in the PTH Gene, Hip Fracture, and Femoral Neck Geometry in Elderly Women
verfasst von
M. Tenne
F. E. McGuigan
H. Ahlborg
P. Gerdhem
K. Åkesson
Publikationsdatum
01.05.2010
Verlag
Springer-Verlag
Erschienen in
Calcified Tissue International / Ausgabe 5/2010
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-010-9351-6

Weitere Artikel der Ausgabe 5/2010

Calcified Tissue International 5/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.